Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
Anne Clavreul,1 Angélique Montagu,2 Anne-Laure Lainé,2 Clément Tétaud,2 Nolwenn Lautram,2 Florence Franconi,3 Catherine Passirani,2 Anne Vessières,4 Claudia N Montero-Menei,2 Philippe Menei1 1Département de Neurochirurgie, Centre Hos...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/78d8165b61a246dfbfa32c0f15c98339 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:78d8165b61a246dfbfa32c0f15c98339 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:78d8165b61a246dfbfa32c0f15c983392021-12-02T03:11:42ZTargeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules1178-2013https://doaj.org/article/78d8165b61a246dfbfa32c0f15c983392015-02-01T00:00:00Zhttp://www.dovepress.com/targeting-and-treatment-of-glioblastomas-with-human-mesenchymal-stem-c-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Anne Clavreul,1 Angélique Montagu,2 Anne-Laure Lainé,2 Clément Tétaud,2 Nolwenn Lautram,2 Florence Franconi,3 Catherine Passirani,2 Anne Vessières,4 Claudia N Montero-Menei,2 Philippe Menei1 1Département de Neurochirurgie, Centre Hospitalier Universitaire, Angers, France; 2INSERM UMR-S 1066, Université d’Angers, LUNAM Université, Angers, France; 3CIFAB-PRIMEX, Université d’Angers, LUNAM Université, Angers, France; 4CNRS-UMR 7223, ENSCP, Paris, France Abstract: Recently developed drug delivery nanosystems, such as lipid nanocapsules (LNCs), hold great promise for the treatment of glioblastomas (GBs). In this study, we used a subpopulation of human mesenchymal stem cells, “marrow-isolated adult multilineage inducible” (MIAMI) cells, which have endogenous tumor-homing activity, to deliver LNCs containing an organometallic complex (ferrociphenol or Fc-diOH), in the orthotopic U87MG GB model. We determined the optimal dose of Fc-diOH-LNCs that can be carried by MIAMI cells and compared the efficacy of Fc-diOH-LNC-loaded MIAMI cells with that of the free-standing Fc-diOH-LNC system. We showed that MIAMI cells entrapped an optimal dose of about 20 pg Fc-diOH per cell, with no effect on cell viability or migration capacity. The survival of U87MG-bearing mice was longer after the intratumoral injection of Fc-diOH-LNC-loaded MIAMI cells than after the injection of Fc-diOH-LNCs alone. The greater effect of the Fc-diOH-LNC-loaded MIAMI cells may be accounted for by their peritumoral distribution and a longer residence time of the drug within the tumor. These results confirm the potential of combinations of stem cell therapy and nanotechnology to improve the local tissue distribution of anticancer drugs in GB.Keywords: glioblastoma, mesenchymal stem cells, nanoparticle, drug delivery, targeting Clavreul AMontagu ALainé ALTétaud CLautram NFranconi FPassirani CVessières AMontero-Menei CNMenei PDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 1259-1271 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Clavreul A Montagu A Lainé AL Tétaud C Lautram N Franconi F Passirani C Vessières A Montero-Menei CN Menei P Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules |
| description |
Anne Clavreul,1 Angélique Montagu,2 Anne-Laure Lainé,2 Clément Tétaud,2 Nolwenn Lautram,2 Florence Franconi,3 Catherine Passirani,2 Anne Vessières,4 Claudia N Montero-Menei,2 Philippe Menei1 1Département de Neurochirurgie, Centre Hospitalier Universitaire, Angers, France; 2INSERM UMR-S 1066, Université d’Angers, LUNAM Université, Angers, France; 3CIFAB-PRIMEX, Université d’Angers, LUNAM Université, Angers, France; 4CNRS-UMR 7223, ENSCP, Paris, France Abstract: Recently developed drug delivery nanosystems, such as lipid nanocapsules (LNCs), hold great promise for the treatment of glioblastomas (GBs). In this study, we used a subpopulation of human mesenchymal stem cells, “marrow-isolated adult multilineage inducible” (MIAMI) cells, which have endogenous tumor-homing activity, to deliver LNCs containing an organometallic complex (ferrociphenol or Fc-diOH), in the orthotopic U87MG GB model. We determined the optimal dose of Fc-diOH-LNCs that can be carried by MIAMI cells and compared the efficacy of Fc-diOH-LNC-loaded MIAMI cells with that of the free-standing Fc-diOH-LNC system. We showed that MIAMI cells entrapped an optimal dose of about 20 pg Fc-diOH per cell, with no effect on cell viability or migration capacity. The survival of U87MG-bearing mice was longer after the intratumoral injection of Fc-diOH-LNC-loaded MIAMI cells than after the injection of Fc-diOH-LNCs alone. The greater effect of the Fc-diOH-LNC-loaded MIAMI cells may be accounted for by their peritumoral distribution and a longer residence time of the drug within the tumor. These results confirm the potential of combinations of stem cell therapy and nanotechnology to improve the local tissue distribution of anticancer drugs in GB.Keywords: glioblastoma, mesenchymal stem cells, nanoparticle, drug delivery, targeting |
| format |
article |
| author |
Clavreul A Montagu A Lainé AL Tétaud C Lautram N Franconi F Passirani C Vessières A Montero-Menei CN Menei P |
| author_facet |
Clavreul A Montagu A Lainé AL Tétaud C Lautram N Franconi F Passirani C Vessières A Montero-Menei CN Menei P |
| author_sort |
Clavreul A |
| title |
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules |
| title_short |
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules |
| title_full |
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules |
| title_fullStr |
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules |
| title_full_unstemmed |
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules |
| title_sort |
targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/78d8165b61a246dfbfa32c0f15c98339 |
| work_keys_str_mv |
AT clavreula targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT montagua targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT laineal targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT tetaudc targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT lautramn targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT franconif targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT passiranic targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT vessieresa targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT monteromeneicn targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules AT meneip targetingandtreatmentofglioblastomaswithhumanmesenchymalstemcellscarryingferrociphenollipidnanocapsules |
| _version_ |
1718401863958659072 |